Jill Mullan was last confirmed as Board Member at iSpecimen Inc. (ISPC) in a filing dated April 10, 2023. Earlier roles on record: COO at iSpecimen Inc. (ISPC) until October 24, 2022. iSpecimen Inc. reported in an 8-K filed October 28, 2022 that Jill Mullan was terminated as officer and manager of the Company, effective October 24, 2022. iSpecimen Inc. reported in an 8-K filed October 28, 2022 that Jill Mullan was terminated as Chief Operating Officer, effective October 24, 2022. The proxy statement of iSpecimen Inc. reports total compensation of $348,750 for Jill Mullan in fiscal 2022, including a base salary of $328,750. Disclosed compensation is on record for 3 fiscal years. Jill Mullan has spoken on 4 earnings calls across 1 company, most recently for iSpecimen Inc. on August 4, 2022. The companies whose calls Jill Mullan spoke on are classified in the Healthcare sector.
“The Company shall take steps to report your removal as an officer and manager of the Company, or any related business entity, including removing references to you as an officer or manager of the Company, on all applicable Company filings and registries.”
iSpecimen Inc. Form 8-K, filed October 28, 2022
· Read the filing
“Dr. Ianelli's employment with the Company and Ms. Mullan's employment with the Company were each terminated on October 24, 2022.”
iSpecimen Inc. Form 8-K, filed October 28, 2022
· Read the filing
Jill Mullan on recent calls
“So we’re really looking at how do we integrate what we call unified search which is bringing the search for biospecimens as well as the search for patients together in one interface.”
“No. So when we look at those orders and we reallocated them to new sites, collection rates varied from when we originally had them allocated to the Ukrainian sites.”
“There's also the supply side and on the supply side which are predominantly the healthcare providers, we know that Omicron impacted their ability to collect specimens.”
“So the enhanced custom collection services allow us to do a couple of things. One is to collect specimens internally at iSpecimen. We have the ability to now recruit patients and bring them to our site and collect the specimens from them.”
